Wegovy drugmaker Novo Nordisk to make $70bn a year from weight-loss alone, as analysts await full SELECT trial data

As researchers work to test whether Novo Nordisk (NYSE:NVO)'s fat-busting drug Wegovy can also be used as a treatment for dementia and alcohol addiction,...

Related Keywords

Copenhagen ,Køavn ,Denmark ,United States ,New York ,American ,Danish ,Martin Holst Lange ,Eli Lilly Mounjaro ,Liraglutide Victoza ,American Heart Association ,Deutsche Bank ,Novo Nordisk ,Eli Lilly ,Holst Lange ,